The Austen BioInnovation Institute in Akron and the University of Akron are planning to launch in January a semester-long educational program aimed at women entrepreneurs. The program will provide participants with access to experts, coaching by successful entrepreneurs, contact with cutting-edge technology and support in forming companies and licensing ideas.
The University of Akron Research Foundation and the Austen BioInnovation Institute were awarded $1 million as winners of a federal competition designed to reward regional collaboration on innovation.
A new report from Relatient, A Data-Driven Guide to Patient Access Succes, highlights how focusing on data accuracy and relevance can enhance the performance of healthcare practices.
An assistant professor of biomedical engineering and an assistant professor of chemical and biomolecular engineering at the University of Akron have been awarded nearly $1 million in Faculty Early Career Development grants by the National Science Foundation (NSF). Both researchers are on teams at the Austen BioInnovation Institute of Akron, of which the university is […]
AKRON — For the past decade, Dr. Judit E. Puskas, professor of polymer science at The University of Akron, has worked to develop a new and innovative breast prosthesis safer for implant patients than the current silicone variety. With one in eight American women diagnosed with breast cancer each year – 70,000 of whom undergo mastectomies […]
Gov. Ted Strickland and Ohio Board of Regents Chancellor Eric Fingerhut donned their high-tech marketing hats Friday, touting the state's leadership in biomedical and health care innovation by announcing centers of excellence at 14 universities.
The Austen BioInnovation Institute in Akron has made its first round of research and development grants: $680 million to eight projects ranging from a contact lens embedded with a sensor that measures blood glucose levels to a polymer platform for drug-eluting prosthetic devices.
When it comes to managing inbound phone calls, underperformance has devastating cost implications.
Northeast Ohio's technology economic development organization, NorTech, has chosen three bioscience products to receive its 2010 Innovation Awards.
NASA's chief of space medicine visited biomedical engineering students at the University of Akron today, as well as doctors and researchers at Summa Health System in Akron, the Northeastern Ohio Universities Colleges of Medicine and Pharmacy in Rootstown and the Austen BioInnovation Institute in Akron to find disruptive medical innovations that can help take care of astronauts.
On its first anniversary, the BioInnovation Institute in Akron added "Austen" to its name, recognizing internationally renown heart surgeon and retiring Knight Foundation Chairman Dr. W. Gerald Austen and his wife Patricia R. Austen. In its first year, the bioinnovation institute has hired an experienced CEO, launched five centers of excellence, attracted nationally recognized board members, and academic and clinical researchers.
Ohio's public universities could transfer more of their research discoveries to companies that can take them to market -- creating new products and jobs -- under an amendment that was part of the recent budget bill.
Join us on February 26 at 3 pm ET, and we’ll dive into the key areas where practices are losing time and money and provide solutions to overcome them.
Margaret Wineman, dean at the College of Nursing at the University of Akron, wants a greater role for nurses in medical homes, primary care, wellness and fighting the H1N1 flu. Some of her thoughts would require changes in Ohio law. But Wineman thinks proposed legislation on medical homes could open the door to expand duties for nurse practitioners.
If all goes well, the two schools could offer a Doctor of Nursing Practice by 2010. Eighty schools already offer the DNP, which the American Association of Colleges of Nursing. Members of the association decided that, by 2015, the DNP will be required for all advanced practice nurses.
Seven out of 10 Innovation Awards to be given Wednesday evening by NorTech and Crain's Cleveland Business will go to companies or institutions that have developed products for the biomedical industry.
Technology transfer -- moving research out of institutions and into companies that can develop and market products with it -- was a healthy enterprise nationwide in fiscal 2007. Northeast Ohio institutions were more successful than those elsewhere in the state at leveraging research spending with licensing revenues.